Search Orphan Drug Designations and Approvals
-
Generic Name: | A10 & AS2-1 Antineoplaston |
---|---|
Date Designated: | 09/03/2004 |
Orphan Designation: | Treatment for patients with brain stem glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Burzynski Research Institute, Inc. 9432 Old Katy Road Houston, Texas 77055 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-